Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

SB 1270Sesión 2025

Qué cambió entre versiones

32 párrafos cambiaron+46 palabras agregadas−48 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

Florida Senate

-

2025

CS for CS for CS for SB 1270

By

the Committee on Rules; the Appropriations Committee on Health and Human Services;

Health and Human Services; the Committee on Health Policy; and Senator Collins

Senator Collins

603-03442-25595-03811-25 20251270c220251270c3

1 A bill to be entitled

410 párrafos sin cambios

2 An act relating to the Department of Health;

3 reenacting ss. 381.00316(2)(g) and 381.00319(1)(e),

4 F.S., relating to the prohibition on discrimination by

5 governmental and business entities based on health

6 care choices and the prohibition on mask mandates and

7 vaccination and testing mandates for educational

8 institutions, respectively, for purposes of preserving

9 the definition of the term “messenger ribonucleic acid

10 vaccine” notwithstanding its scheduled repeal;

11 repealing s. 9 of chapter 2023-43, Laws of Florida,

12 which provides for the repeal of the definition of the

13 term “messenger ribonucleic acid vaccine”; amending s.

14 381.026, F.S.; revising the rights of patients, which

15 each health care provider and facility are required to

16 observe, to include that such facilities and providers

17 may not discriminate based on a patient’s vaccination

18 status; amending s. 381.986, F.S.; defining terms for

19 purposes of background screening requirements for

20 persons affiliated with medical marijuana treatment

21 centers; requiring medical marijuana treatment centers

22 to notify the Department of Health through electronic

23 mail within a specified timeframe after an actual or

24 attempted theft, diversion, or loss of marijuana;

25 requiring medical marijuana treatment centers to

26 report attempted thefts, in addition to actual thefts,

27 to law enforcement within a specified timeframe;

28 amending s. 381.988, F.S.; defining terms for purposes

29 of background screening requirements for persons

30 affiliated with medical marijuana testing

31 laboratories; amending s. 456.0145, F.S.; revising

32 eligibility criteria for licensure by endorsement

33 under the MOBILE Act; amending ss. 458.315 and

34 459.0076, F.S.; authorizing certain physician

35 assistants to be issued temporary certificates for

36 practice in areas of critical need; amending s.

37 486.112, F.S.; defining the term “party state”;

38 authorizing a remote state to issue subpoenas to

39 individuals to testify or for the production of

40 evidence from a party located in a party state;

41 providing that such subpoenas are enforceable in the

42 party state; requiring that investigative information

43 pertaining to certain licensees in a certain system be

44 available only to other party states; revising

45 construction and severability of the compact to

46 conform to changes made by the act; amending s.

47 766.1115, F.S.; revising the definition of the term

48 “health care provider” or “provider”; providing

49 effective dates.

50

51 Be It Enacted by the Legislature of the State of Florida:

52

53 Section 1. Effective upon becoming a law, or, if this act

54 fails to become a law until after June 1, 2025, operating

55 retroactively to June 1, 2025, notwithstanding the scheduled

56 repeal in section 9 of chapter 2023-43, Laws of Florida,

57 paragraph (g) of subsection (2) of section 381.00316, Florida

58 Statutes, is reenacted to read:

59 381.00316 Discrimination by governmental and business

60 entities based on health care choices; prohibition.—

61 (2) As used in this section, the term:

62 (g) “Messenger ribonucleic acid vaccine” means any vaccine

63 that uses laboratory-produced messenger ribonucleic acid to

64 trigger the human body’s immune system to generate an immune

65 response.

66 Section 2. Effective upon becoming a law, or, if this act

67 fails to become a law until after June 1, 2025, operating

68 retroactively to June 1, 2025, notwithstanding the scheduled

69 repeal in section 9 of chapter 2023-43, Laws of Florida,

70 paragraph (e) of subsection (1) of section 381.00319, Florida

71 Statutes, is reenacted to read:

72 381.00319 Prohibition on mask mandates and vaccination and

73 testing mandates for educational institutions.—

74 (1) For purposes of this section, the term:

75 (e) “Messenger ribonucleic acid vaccine” has the same

76 meaning as in s. 381.00316.

77 Section 3.

Effective upon becoming a law, or

,

if this act

78

fails to become a law until after June 1, 2025, operating

79

retroactively to June 1, 2025

,

section

9 of chapter 2023-43,

80

Laws of Florida, is repealed.

81 Section 4. Paragraphs (b) and (d) of subsection (4) and

82 subsection (6) of section 381.026, Florida Statutes, are amended

83 to read:

84 381.026 Florida Patient’s Bill of Rights and

85 Responsibilities.—

86 (4) RIGHTS OF PATIENTS.—Each health care facility or

87 provider shall observe the following standards:

88 (b)

Information.

—

89 1. A patient has the right to know the name, function, and

90 qualifications of each health care provider who is providing

91 medical services to the patient. A patient may request such

92 information from his or her responsible provider or the health

93 care facility in which he or she is receiving medical services.

94 2. A patient in a health care facility has the right to

95 know what patient support services are available in the

96 facility.

97 3. A patient has the right to be given by his or her health

98 care provider information concerning diagnosis, planned course

99 of treatment, alternatives, risks, and prognosis, unless it is

100 medically inadvisable or impossible to give this information to

101 the patient, in which case the information must be given to the

102 patient’s guardian or a person designated as the patient’s

103 representative. A patient has the right to refuse this

104 information.

105 4. A patient has the right to refuse any treatment based on

106 information required by this paragraph, except as otherwise

107 provided by law. The responsible provider shall document any

108 such refusal.

109 5. A patient in a health care facility has the right to

110 know what facility rules and regulations apply to patient

111 conduct.

112 6. A patient has the right to express grievances to a

113 health care provider, a health care facility, or the appropriate

114 state licensing agency regarding alleged violations of patients’

115 rights. A patient has the right to know the health care

116 provider’s or health care facility’s procedures for expressing a

117 grievance.

118 7. A patient in a health care facility who does not speak

119 English has the right to be provided an interpreter when

120 receiving medical services if the facility has a person readily

121 available who can interpret on behalf of the patient.

122 8. A health care provider or health care facility shall

123 respect a patient’s right to privacy and should refrain from

124 making a written inquiry or asking questions concerning the

125 ownership of a firearm or ammunition by the patient or by a

126 family member of the patient, or the presence of a firearm in a

127 private home or other domicile of the patient or a family member

128 of the patient. Notwithstanding this provision, a health care

129 provider or health care facility that in good faith believes

130 that this information is relevant to the patient’s medical care

131 or safety, or safety of others, may make such a verbal or

132 written inquiry.

133 9. A patient may decline to answer or provide any

134 information regarding ownership of a firearm by the patient or a

135 family member of the patient, or the presence of a firearm in

136 the domicile of the patient or a family member of the patient. A

137 patient’s decision not to answer a question relating to the

138 presence or ownership of a firearm does not alter existing law

139 regarding a physician’s authorization to choose his or her

140 patients.

141 10. A health care provider or health care facility may not

142 discriminate against a patient based solely upon the patient’s

143 exercise of the constitutional right to own and possess firearms

144 or ammunition.

145 11. A health care provider or health care facility shall

146 respect a patient’s legal right to own or possess a firearm and

147 should refrain from unnecessarily harassing a patient about

148 firearm ownership during an examination.

149

12.

A health care provider or health care facility may not

150

discriminate against a patient based solely upon the patient’s

151

vaccination status.

152 (d)

Access to health care.

—

153 1. A patient has the right to impartial access to medical

154 treatment or accommodations, regardless of race, national

155 origin, religion, handicap,

vaccination status,

or source of

156 payment.

157 2. A patient has the right to treatment for any emergency

158 medical condition that will deteriorate from failure to provide

159 such treatment.

160 3. A patient has the right to access any mode of treatment

161 that is, in his or her own judgment and the judgment of his or

162 her health care practitioner, in the best interests of the

163 patient, including complementary or alternative health care

164 treatments, in accordance with the provisions of s. 456.41.

165 (6) SUMMARY OF RIGHTS AND RESPONSIBILITIES.—Any health care

166 provider who treats a patient in an office or any health care

167 facility licensed under chapter 395 that provides emergency

168 services and care or outpatient services and care to a patient,

169 or admits and treats a patient, shall adopt and make available

170 to the patient, in writing, a statement of the rights and

171 responsibilities of patients, including the following:

172

173 SUMMARY OF THE FLORIDA PATIENT’S BILL

174 OF RIGHTS AND RESPONSIBILITIES

175

176 Florida law requires that your health care

177 provider or health care facility recognize your rights

178 while you are receiving medical care and that you

179 respect the health care provider’s or health care

180 facility’s right to expect certain behavior on the

181 part of patients. You may request a copy of the full

182 text of this law from your health care provider or

183 health care facility. A summary of your rights and

184 responsibilities follows:

185 A patient has the right to be treated with

186 courtesy and respect, with appreciation of his or her

187 individual dignity, and with protection of his or her

188 need for privacy.

189 A patient has the right to a prompt and

190 reasonable response to questions and requests.

191 A patient has the right to know who is providing

192 medical services and who is responsible for his or her

193 care.

194 A patient has the right to know what patient

195 support services are available, including whether an

196 interpreter is available if he or she does not speak

197 English.

198 A patient has the right to bring any person of

199 his or her choosing to the patient-accessible areas of

200 the health care facility or provider’s office to

201 accompany the patient while the patient is receiving

202 inpatient or outpatient treatment or is consulting

203 with his or her health care provider, unless doing so

204 would risk the safety or health of the patient, other

205 patients, or staff of the facility or office or cannot

206 be reasonably accommodated by the facility or

207 provider.

208 A patient has the right to know what rules and

209 regulations apply to his or her conduct.

210 A patient has the right to be given by the health

211 care provider information concerning diagnosis,

212 planned course of treatment, alternatives, risks, and

213 prognosis.

214 A patient has the right to refuse any treatment,

215 except as otherwise provided by law.

216 A patient has the right to be given, upon

217 request, full information and necessary counseling on

218 the availability of known financial resources for his

219 or her care.

220 A patient who is eligible for Medicare has the

221 right to know, upon request and in advance of

222 treatment, whether the health care provider or health

223 care facility accepts the Medicare assignment rate.

224 A patient has the right to receive, upon request,

225 prior to treatment, a reasonable estimate of charges

226 for medical care.

227 A patient has the right to receive a copy of a

228 reasonably clear and understandable, itemized bill

229 and, upon request, to have the charges explained.

230 A patient has the right to impartial access to

231 medical treatment or accommodations, regardless of

232 race, national origin, religion, handicap,

vaccination

233

status,

or source of payment.

234 A patient has the right to treatment for any

235 emergency medical condition that will deteriorate from

236 failure to provide treatment.

237 A patient has the right to know if medical

238 treatment is for purposes of experimental research and

239 to give his or her consent or refusal to participate

240 in such experimental research.

241 A patient has the right to express grievances

242 regarding any violation of his or her rights, as

243 stated in Florida law, through the grievance procedure

244 of the health care provider or health care facility

245 which served him or her and to the appropriate state

246 licensing agency.

247 A patient is responsible for providing to the

248 health care provider, to the best of his or her

249 knowledge, accurate and complete information about

250 present complaints, past illnesses, hospitalizations,

251 medications, and other matters relating to his or her

252 health.

253 A patient is responsible for reporting unexpected

254 changes in his or her condition to the health care

255 provider.

256 A patient is responsible for reporting to the

257 health care provider whether he or she comprehends a

258 contemplated course of action and what is expected of

259 him or her.

260 A patient is responsible for following the

261 treatment plan recommended by the health care

262 provider.

263 A patient is responsible for keeping appointments

264 and, when he or she is unable to do so for any reason,

265 for notifying the health care provider or health care

266 facility.

267 A patient is responsible for his or her actions

268 if he or she refuses treatment or does not follow the

269 health care provider’s instructions.

270 A patient is responsible for assuring that the

271 financial obligations of his or her health care are

272 fulfilled as promptly as possible.

273 A patient is responsible for following health

274 care facility rules and regulations affecting patient

275 care and conduct.

276

277 Section 5. Paragraphs (b), (e), and (f) of subsection (8)

278 of section 381.986, Florida Statutes, are amended to read:

279 381.986 Medical use of marijuana.—

280 (8) MEDICAL MARIJUANA TREATMENT CENTERS.—

281 (b) An applicant for licensure as a medical marijuana

282 treatment center

must

shall

apply to the department on a form

283 prescribed by the department and adopted in rule. The department

284 shall adopt rules pursuant to ss. 120.536(1) and 120.54

285 establishing a procedure for the issuance and biennial renewal

286 of licenses, including initial application and biennial renewal

287 fees sufficient to cover the costs of implementing and

288 administering this section, and establishing supplemental

289 licensure fees for payment beginning May 1, 2018, sufficient to

290 cover the costs of administering ss. 381.989 and 1004.4351. The

291 department shall identify applicants with strong diversity plans

292 reflecting this state’s commitment to diversity and implement

293 training programs and other educational programs to enable

294 minority persons and minority business enterprises, as defined

295 in s. 288.703, and veteran business enterprises, as defined in

296 s. 295.187, to compete for medical marijuana treatment center

297 licensure and contracts. Subject to the requirements in

298 subparagraphs (a)2.-4., the department shall issue a license to

299 an applicant if the applicant meets the requirements of this

300 section and pays the initial application fee. The department

301 shall renew the licensure of a medical marijuana treatment

302 center biennially if the licensee meets the requirements of this

303 section and pays the biennial renewal fee. However, the

304 department may not renew the license of a medical marijuana

305 treatment center that has not begun to cultivate, process, and

306 dispense marijuana by the date that the medical marijuana

307 treatment center is required to renew its license. An individual

308 may not be an applicant, owner, officer, board member, or

309 manager on more than one application for licensure as a medical

310 marijuana treatment center. An individual or entity may not be

311 awarded more than one license as a medical marijuana treatment

312 center. An applicant for licensure as a medical marijuana

313 treatment center must demonstrate:

314 1. That, for the 5 consecutive years before submitting the

315 application, the applicant has been registered to do business in

316

this

the

state.

317 2. Possession of a valid certificate of registration issued

318 by the Department of Agriculture and Consumer Services pursuant

319 to s. 581.131.

320 3. The technical and technological ability to cultivate and

321 produce marijuana, including, but not limited to, low-THC

322 cannabis.

323 4. The ability to secure the premises, resources, and

324 personnel necessary to operate as a medical marijuana treatment

325 center.

326 5. The ability to maintain accountability of all raw

327 materials, finished products, and any byproducts to prevent

328 diversion or unlawful access to or possession of these

329 substances.

330 6. An infrastructure reasonably located to dispense

331 marijuana to registered qualified patients statewide or

332 regionally as determined by the department.

333 7. The financial ability to maintain operations for the

334 duration of the 2-year approval cycle, including the provision

335 of certified financial statements to the department.

336 a. Upon approval, the applicant must post a $5 million

337 performance bond issued by an authorized surety insurance

338 company rated in one of the three highest rating categories by a

339 nationally recognized rating service. However, a medical

340 marijuana treatment center serving at least 1,000 qualified

341 patients is only required to maintain a $2 million performance

342 bond.

343 b. In lieu of the performance bond required under sub

344 subparagraph a., the applicant may provide an irrevocable letter

345 of credit payable to the department or provide cash to the

346 department. If provided with cash under this sub-subparagraph,

347 the department

must

shall

deposit the cash in the Grants and

348 Donations Trust Fund within the Department of Health, subject to

349 the same conditions as the bond regarding requirements for the

350 applicant to forfeit ownership of the funds. If the funds

351 deposited under this sub-subparagraph generate interest, the

352 amount of that interest

must

shall

be used by the department for

353 the administration of this section.

354 8. That all owners

, officers, board members,

and managers

355 have passed a background screening pursuant to subsection (9).

356

As used in this subparagraph, the term:

357

a.

“Manager” means any person with the authority to

358

exercise or contribute to the operational control, direction

,

or

359

management of an applicant or a medical marijuana treatment

360

center or who has authority to supervise any employee of an

361

applicant or a medical marijuana treatment center. Th

e term

362

includes an individual with the power or authority to direct or

363

influence the direction or operation of an applicant or a

364

medical marijuana treatment center through board membership, an

365

voting power, an agreement, or a contract

.

456 párrafos sin cambios

366

b.

“Owner”

means any person who owns or controls a 5

367

percent

or greater share of interests of the applicant or a

368

medical marijuana treatment center which include beneficial or

369

voting rights to interests. In the event that one person owns a

370

beneficial right to interests and another person holds the

371

voting rights with respect to such interests, then in such case,

372

both

are

considered the owner of such interests.

373 9. The employment of a medical director to supervise the

374 activities of the medical marijuana treatment center.

375 10. A diversity plan that promotes and ensures the

376 involvement of minority persons and minority business

377 enterprises, as defined in s. 288.703, or veteran business

378 enterprises, as defined in s. 295.187, in ownership, management,

379 and employment. An applicant for licensure renewal must show the

380 effectiveness of the diversity plan by including the following

381 with his or her application for renewal:

382 a. Representation of minority persons and veterans in the

383 medical marijuana treatment center’s workforce;

384 b. Efforts to recruit minority persons and veterans for

385 employment; and

386 c. A record of contracts for services with minority

387 business enterprises and veteran business enterprises.

388 (e) A licensed medical marijuana treatment center shall

389 cultivate, process, transport, and dispense marijuana for

390 medical use. A licensed medical marijuana treatment center may

391 not contract for services directly related to the cultivation,

392 processing, and dispensing of marijuana or marijuana delivery

393 devices, except that a medical marijuana treatment center

394 licensed pursuant to subparagraph (a)1. may contract with a

395 single entity for the cultivation, processing, transporting, and

396 dispensing of marijuana and marijuana delivery devices. A

397 licensed medical marijuana treatment center

shall

must

, at all

398 times, maintain compliance with the criteria demonstrated and

399 representations made in the initial application and the criteria

400 established in this subsection. Upon request, the department may

401 grant a medical marijuana treatment center a variance from the

402 representations made in the initial application. Consideration

403 of such a request

must

shall

be based upon the individual facts

404 and circumstances surrounding the request. A variance may not be

405 granted unless the requesting medical marijuana treatment center

406 can demonstrate to the department that it has a proposed

407 alternative to the specific representation made in its

408 application which fulfills the same or a similar purpose as the

409 specific representation in a way that the department can

410 reasonably determine will not be a lower standard than the

411 specific representation in the application. A variance may not

412 be granted from the requirements in subparagraph 2. and

413 subparagraphs (b)1. and 2.

414 1. A licensed medical marijuana treatment center may

415 transfer ownership to an individual or entity who meets the

416 requirements of this section. A publicly traded corporation or

417 publicly traded company that meets the requirements of this

418 section is not precluded from ownership of a medical marijuana

419 treatment center. To accommodate a change in ownership:

420 a. The licensed medical marijuana treatment center shall

421 notify the department in writing at least 60 days before the

422 anticipated date of the change of ownership.

423 b. The individual or entity applying for initial licensure

424 due to a change of ownership must submit an application that

425 must be received by the department at least 60 days before the

426 date of change of ownership.

427 c. Upon receipt of an application for a license, the

428 department shall examine the application and, within 30 days

429 after receipt, notify the applicant in writing of any apparent

430 errors or omissions and request any additional information

431 required.

432 d. Requested information omitted from an application for

433 licensure must be filed with the department within 21 days after

434 the department’s request for omitted information or the

435 application

will

shall

be deemed incomplete and

shall be

436 withdrawn from further consideration and the fees

shall be

437 forfeited.

438 e. Within 30 days after the receipt of a complete

439 application, the department shall approve or deny the

440 application.

441 2. A medical marijuana treatment center, and any individual

442 or entity who directly or indirectly owns, controls, or holds

443 with power to vote 5 percent or more of the voting shares of a

444 medical marijuana treatment center, may not acquire direct or

445 indirect ownership or control of any voting shares or other form

446 of ownership of any other medical marijuana treatment center.

447 3. A medical marijuana treatment center may not enter into

448 any form of profit-sharing arrangement with the property owner

449 or lessor of any of its facilities where cultivation,

450 processing, storing, or dispensing of marijuana and marijuana

451 delivery devices occurs.

452 4. All employees of a medical marijuana treatment center

453 must be 21 years of age or older and have passed a background

454 screening pursuant to subsection (9).

As used in this

455

subparagraph

,

the term

“employee” means any person employed by a

456

medical marijuana treatment center licensee in any capacity,

457

including those whose duties involve any aspect of the

458

cultivation, processing, transportation

,

or dispensing of

459

marijuana. This requirement applies to all employees,

regardless

460

of

the

compensation received.

461 5. Each medical marijuana treatment center must adopt and

462 enforce policies and procedures to ensure employees and

463 volunteers receive training on the legal requirements to

464 dispense marijuana to qualified patients.

465 6. When growing marijuana, a medical marijuana treatment

466 center:

467 a. May use pesticides determined by the department, after

468 consultation with the Department of Agriculture and Consumer

469 Services, to be safely applied to plants intended for human

470 consumption, but may not use pesticides designated as

471 restricted-use pesticides pursuant to s. 487.042.

472 b. Must grow marijuana within an enclosed structure and in

473 a room separate from any other plant.

474 c. Must inspect seeds and growing plants for plant pests

475 that endanger or threaten the horticultural and agricultural

476 interests of the state in accordance with chapter 581 and any

477 rules adopted thereunder.

478 d. Must perform fumigation or treatment of plants, or

479 remove and destroy infested or infected plants, in accordance

480 with chapter 581 and any rules adopted thereunder.

481 7. Each medical marijuana treatment center must produce and

482 make available for purchase at least one low-THC cannabis

483 product.

484 8. A medical marijuana treatment center that produces

485 edibles must hold a permit to operate as a food establishment

486 pursuant to chapter 500, the Florida Food Safety Act, and must

487 comply with all the requirements for food establishments

488 pursuant to chapter 500 and any rules adopted thereunder.

489 Edibles may not contain more than 200 milligrams of

490 tetrahydrocannabinol, and a single serving portion of an edible

491 may not exceed 10 milligrams of tetrahydrocannabinol. Edibles

492 may

not

have a potency variance

of no

greater than 15 percent.

493 Marijuana products, including edibles, may not be attractive to

494 children; be manufactured in the shape of humans, cartoons, or

495 animals; be manufactured in a form that bears any reasonable

496 resemblance to products available for consumption as

497 commercially available candy; or contain any color additives. To

498 discourage consumption of edibles by children, the department

499 shall determine by rule any shapes, forms, and ingredients

500 allowed and prohibited for edibles. Medical marijuana treatment

501 centers may not begin processing or dispensing edibles until

502 after the effective date of the rule. The department shall also

503 adopt sanitation rules providing the standards and requirements

504 for the storage, display, or dispensing of edibles.

505 9. Within 12 months after licensure, a medical marijuana

506 treatment center must demonstrate to the department that all of

507 its processing facilities have passed a Food Safety Good

508 Manufacturing Practices, such as Global Food Safety Initiative

509 or equivalent, inspection by a nationally accredited certifying

510 body. A medical marijuana treatment center must immediately stop

511 processing at any facility which fails to pass this inspection

512 until it demonstrates to the department that such facility has

513 met this requirement.

514 10. A medical marijuana treatment center that produces

515 prerolled marijuana cigarettes may not use wrapping paper made

516 with tobacco or hemp.

517 11. When processing marijuana, a medical marijuana

518 treatment center must:

519 a. Process the marijuana within an enclosed structure and

520 in a room separate from other plants or products.

521 b. Comply with department rules when processing marijuana

522 with hydrocarbon solvents or other solvents or gases exhibiting

523 potential toxicity to humans. The department shall determine by

524 rule the requirements for medical marijuana treatment centers to

525 use such solvents or gases exhibiting potential toxicity to

526 humans.

527 c. Comply with federal and state laws and regulations and

528 department rules for solid and liquid wastes. The department

529 shall determine by rule procedures for the storage, handling,

530 transportation, management, and disposal of solid and liquid

531 waste generated during marijuana production and processing. The

532 Department of Environmental Protection shall assist the

533 department in developing such rules.

534 d. Test the processed marijuana using a medical marijuana

535 testing laboratory before it is dispensed. Results must be

536 verified and signed by two medical marijuana treatment center

537 employees. Before dispensing, the medical marijuana treatment

538 center must determine that the test results indicate that low

539 THC cannabis meets the definition of low-THC cannabis, the

540 concentration of tetrahydrocannabinol meets the potency

541 requirements of this section, the labeling of the concentration

542 of tetrahydrocannabinol and cannabidiol is accurate, and all

543 marijuana is safe for human consumption and free from

544 contaminants that are unsafe for human consumption. The

545 department shall determine by rule which contaminants must be

546 tested for and the maximum levels of each contaminant which are

547 safe for human consumption. The Department of Agriculture and

548 Consumer Services shall assist the department in developing the

549 testing requirements for contaminants that are unsafe for human

550 consumption in edibles. The department shall also determine by

551 rule the procedures for the treatment of marijuana that fails to

552 meet the testing requirements of this section, s. 381.988, or

553 department rule. The department may select samples of marijuana

554 from a medical marijuana treatment center facility which shall

555 be tested by the department to determine whether the marijuana

556 meets the potency requirements of this section, is safe for

557 human consumption, and is accurately labeled with the

558 tetrahydrocannabinol and cannabidiol concentration or to verify

559 the result of marijuana testing conducted by a marijuana testing

560 laboratory. The department may also select samples of marijuana

561 delivery devices from a medical marijuana treatment center to

562 determine whether the marijuana delivery device is safe for use

563 by qualified patients. A medical marijuana treatment center may

564 not require payment from the department for the sample. A

565 medical marijuana treatment center must recall marijuana,

566 including all marijuana and marijuana products made from the

567 same batch of marijuana, that fails to meet the potency

568 requirements of this section, that is unsafe for human

569 consumption, or for which the labeling of the

570 tetrahydrocannabinol and cannabidiol concentration is

571 inaccurate. The department shall adopt rules to establish

572 marijuana potency variations of no greater than 15 percent using

573 negotiated rulemaking pursuant to s. 120.54(2)(d) which accounts

574 for, but is not limited to, time lapses between testing, testing

575 methods, testing instruments, and types of marijuana sampled for

576 testing. The department may not issue any recalls for product

577 potency as it relates to product labeling before issuing a rule

578 relating to potency variation standards. A medical marijuana

579 treatment center must also recall all marijuana delivery devices

580 determined to be unsafe for use by qualified patients. The

581 medical marijuana treatment center must retain records of all

582 testing and samples of each homogeneous batch of marijuana for

583 at least 9 months. The medical marijuana treatment center must

584 contract with a marijuana testing laboratory to perform audits

585 on the medical marijuana treatment center’s standard operating

586 procedures, testing records, and samples and provide the results

587 to the department to confirm that the marijuana or low-THC

588 cannabis meets the requirements of this section and that the

589 marijuana or low-THC cannabis is safe for human consumption. A

590 medical marijuana treatment center shall reserve two processed

591 samples from each batch and retain such samples for at least 9

592 months for the purpose of such audits. A medical marijuana

593 treatment center may use a laboratory that has not been

594 certified by the department under s. 381.988 until such time as

595 at least one laboratory holds the required certification, but in

596 no event later than July 1, 2018.

597 e. Package the marijuana in compliance with the United

598 States Poison Prevention Packaging Act of 1970, 15 U.S.C. ss.

599 1471 et seq.

600 f. Package the marijuana in a receptacle that has a firmly

601 affixed and legible label stating the following information:

602 (I) The marijuana or low-THC cannabis meets the

603 requirements of sub-subparagraph d.

604 (II) The name of the medical marijuana treatment center

605 from which the marijuana originates.

606 (III) The batch number and harvest number from which the

607 marijuana originates and the date dispensed.

608 (IV) The name of the physician who issued the physician

609 certification.

610 (V) The name of the patient.

611 (VI) The product name, if applicable, and dosage form,

612 including concentration of tetrahydrocannabinol and cannabidiol.

613 The product name may not contain wording commonly associated

614 with products that are attractive to children or which promote

615 the recreational use of marijuana.

616 (VII) The recommended dose.

617 (VIII) A warning that it is illegal to transfer medical

618 marijuana to another person.

619 (IX) A marijuana universal symbol developed by the

620 department.

621 12. The medical marijuana treatment center shall include in

622 each package a patient package insert with information on the

623 specific product dispensed related to:

624 a. Clinical pharmacology.

625 b. Indications and use.

626 c. Dosage and administration.

627 d. Dosage forms and strengths.

628 e. Contraindications.

629 f. Warnings and precautions.

630 g. Adverse reactions.

631 13. In addition to the packaging and labeling requirements

632 specified in subparagraphs 11. and 12., marijuana in a form for

633 smoking must be packaged in a sealed receptacle with a legible

634 and prominent warning to keep away from children and a warning

635 that states marijuana smoke contains carcinogens and may

636 negatively affect health. Such receptacles for marijuana in a

637 form for smoking must be plain, opaque, and white without

638 depictions of the product or images other than the medical

639 marijuana treatment center’s department-approved logo and the

640 marijuana universal symbol.

641 14. The department shall adopt rules to regulate the types,

642 appearance, and labeling of marijuana delivery devices dispensed

643 from a medical marijuana treatment center. The rules must

644 require marijuana delivery devices to have an appearance

645 consistent with medical use.

646 15. Each edible must be individually sealed in plain,

647 opaque wrapping marked only with the marijuana universal symbol.

648 Where practical, each edible must be marked with the marijuana

649 universal symbol. In addition to the packaging and labeling

650 requirements in subparagraphs 11. and 12., edible receptacles

651 must be plain, opaque, and white without depictions of the

652 product or images other than the medical marijuana treatment

653 center’s department-approved logo and the marijuana universal

654 symbol. The receptacle must also include a list of all the

655 edible’s ingredients, storage instructions, an expiration date,

656 a legible and prominent warning to keep away from children and

657 pets, and a warning that the edible has not been produced or

658 inspected pursuant to federal food safety laws.

659 16. When dispensing marijuana or a marijuana delivery

660 device, a medical marijuana treatment center:

661 a. May dispense any active, valid order for low-THC

662 cannabis, medical cannabis and cannabis delivery devices issued

663 pursuant to former s. 381.986, Florida Statutes 2016, which was

664 entered into the medical marijuana use registry before July 1,

665 2017.

666 b. May not dispense more than a 70-day supply of marijuana

667 within any 70-day period to a qualified patient or caregiver.

668 May not dispense more than one 35-day supply of marijuana in a

669 form for smoking within any 35-day period to a qualified patient

670 or caregiver. A 35-day supply of marijuana in a form for smoking

671 may not exceed 2.5 ounces unless an exception to this amount is

672 approved by the department pursuant to paragraph (4)(f).

673 c. Must have the medical marijuana treatment center’s

674 employee who dispenses the marijuana or a marijuana delivery

675 device enter into the medical marijuana use registry his or her

676 name or unique employee identifier.

677 d. Must verify that the qualified patient and the

678 caregiver, if applicable, each have an active registration in

679 the medical marijuana use registry and an active and valid

680 medical marijuana use registry identification card, the amount

681 and type of marijuana dispensed matches the physician

682 certification in the medical marijuana use registry for that

683 qualified patient, and the physician certification has not

684 already been filled.

685 e. May not dispense marijuana to a qualified patient who is

686 younger than 18 years of age. If the qualified patient is

687 younger than 18 years of age, marijuana may only be dispensed to

688 the qualified patient’s caregiver.

689 f. May not dispense or sell any other type of cannabis,

690 alcohol, or illicit drug-related product, including pipes or

691 wrapping papers made with tobacco or hemp, other than a

692 marijuana delivery device required for the medical use of

693 marijuana and which is specified in a physician certification.

694 g. Must, upon dispensing the marijuana or marijuana

695 delivery device, record in the registry the date, time,

696 quantity, and form of marijuana dispensed; the type of marijuana

697 delivery device dispensed; and the name and medical marijuana

698 use registry identification number of the qualified patient or

699 caregiver to whom the marijuana delivery device was dispensed.

700 h. Must ensure that patient records are not visible to

701 anyone other than the qualified patient, his or her caregiver,

702 and authorized medical marijuana treatment center employees.

703 (f) To ensure the safety and security of premises where the

704 cultivation, processing, storing, or dispensing of marijuana

705 occurs, and to maintain adequate controls against the diversion,

706 theft, and loss of marijuana or marijuana delivery devices, a

707 medical marijuana treatment center shall:

708 1.a. Maintain a fully operational security alarm system

709 that secures all entry points and perimeter windows and is

710 equipped with motion detectors; pressure switches; and duress,

711 panic, and hold-up alarms; and

712 b. Maintain a video surveillance system that records

713 continuously 24 hours a day and meets the following criteria:

714 (I) Cameras are fixed in a place that allows for the clear

715 identification of persons and activities in controlled areas of

716 the premises. Controlled areas include grow rooms, processing

717 rooms, storage rooms, disposal rooms or areas, and point-of-sale

718 rooms.

719 (II) Cameras are fixed in entrances and exits to the

720 premises, which

must

shall

record from both indoor and outdoor,

721 or ingress and egress, vantage points.

722 (III) Recorded images must clearly and accurately display

723 the time and date.

724 (IV) Retain video surveillance recordings for at least 45

725 days or longer upon the request of a law enforcement agency.

726 2. Ensure that the medical marijuana treatment center’s

727 outdoor premises have sufficient lighting from dusk until dawn.

728 3. Ensure that the indoor premises where dispensing occurs

729 includes a waiting area with sufficient space and seating to

730 accommodate qualified patients and caregivers and at least one

731 private consultation area that is isolated from the waiting area

732 and area where dispensing occurs. A medical marijuana treatment

733 center may not display products or dispense marijuana or

734 marijuana delivery devices in the waiting area.

735 4. Not dispense from its premises marijuana or a marijuana

736 delivery device between the hours of 9 p.m. and 7 a.m., but may

737 perform all other operations and deliver marijuana to qualified

738 patients 24 hours a day.

739 5. Store marijuana in a secured, locked room or a vault.

740 6. Require at least two of its employees, or two employees

741 of a security agency with whom it contracts, to be on the

742 premises at all times where cultivation, processing, or storing

743 of marijuana occurs.

744 7. Require each employee or contractor to wear a photo

745 identification badge at all times while on the premises.

746 8. Require each visitor to wear a visitor pass at all times

747 while on the premises.

748 9. Implement an alcohol and drug-free workplace policy.

749 10. Report to local law enforcement

and notify the

750

department through e-mail

within 24 hours after the medical

751 marijuana treatment center is notified or becomes aware of

any

752

actual or attempted

the

theft, diversion, or loss of marijuana.

753 Section 6. Paragraph (d) of subsection (1) of section

754 381.988, Florida Statutes, is amended to read:

755 381.988 Medical marijuana testing laboratories; marijuana

756 tests conducted by a certified laboratory.—

757 (1) A person or entity seeking to be a certified marijuana

758 testing laboratory must:

759 (d) Require all employees, owners, and managers to submit

760 to and pass a level 2 background screening pursuant to chapter

761 435. The department shall deny certification if the person or

762 entity seeking certification has a disqualifying offense as

763 provided in s. 435.04 or has an arrest awaiting final

764 disposition for, has been found guilty of, or has entered a plea

765 of guilty or nolo contendere to, regardless of adjudication, any

766 offense listed in chapter 837, chapter 895, or chapter 896 or

767 similar law of another jurisdiction. Exemptions from

768 disqualification as provided under s. 435.07 do not apply to

769 this paragraph.

770 1.

As used in

As used in this paragraph, the term:

, the term

:

771

6 párrafos sin cambios

a.

“Employee” means any person whose duties or activities

772

involve any aspect of regulatory compliance testing or research

773

and development testing of marijuana for a certified marijuana

774

testing laboratory, regardless of whether such person is

regardless of

whether

such person is

775

compensated for his or her work.

his or her

work.

776

4 párrafos sin cambios

b.

“Manager” means any person with authority to exercise or

777

contribute to the operational control, direction, or management

778

of an

a

pplicantof an applicant or certified marijuana testing laboratory or who

779

has authority to supervise any employee of an applicant or a

e

mployee of an

a

pplicant or a

780

certified marijuana testing laboratory. ThThe term includes an

e

term includes an

781

3 párrafos sin cambios

individual with the power or authority to direct or influence

782

the direction or operation of an applicant or a certified

783

marijuana testing laboratory through board membership, votingan

784

power, an agreement, or a contract.

.

785

1036 párrafos sin cambios

c.

“Owner” means any person who owns or controls a 5

786

percent

or greater share of interests of the applicant or a

787

certified marijuana testing laboratory which include beneficial

788

or voting rights to interests. In the event that one person owns

789

a beneficial right to interests and another person holds the

790

voting rights with respect to such interests, then in such case,

791

both

are

considered the owner of such interests.

792

2.

Such employees, owners, and managers must submit a full

793 set of fingerprints to the department or to a vendor, entity, or

794 agency authorized by s. 943.053(13). The department, vendor,

795 entity, or agency shall forward the fingerprints to the

796 Department of Law Enforcement for state processing, and the

797 Department of Law Enforcement shall forward the fingerprints to

798 the Federal Bureau of Investigation for national processing.

799

3.

2.

Fees for state and federal fingerprint processing and

800 retention

must

shall

be borne by the certified marijuana testing

801 laboratory. The state cost for fingerprint processing

is

shall

802

be

as provided in s. 943.053(3)(e) for records provided to

803 persons or entities other than those specified as exceptions

804 therein.

805

4.

3.

Fingerprints submitted to the Department of Law

806 Enforcement pursuant to this paragraph

must

shall

be retained by

807 the Department of Law Enforcement as provided in s. 943.05(2)(g)

808 and (h) and, when the Department of Law Enforcement begins

809 participation in the program, enrolled in the Federal Bureau of

810 Investigation’s national retained print arrest notification

811 program. Any arrest record identified

must

shall

be reported to

812 the department.

813 Section 7. Paragraph (c) of subsection (2) of section

814 456.0145, Florida Statutes, is amended to read:

815 456.0145 Mobile Opportunity by Interstate Licensure

816 Endorsement (MOBILE) Act.—

817 (2) LICENSURE BY ENDORSEMENT.—

818 (c) A person is ineligible for a license under this section

819 if he or she:

820 1. Has a complaint, an allegation, or an investigation

821 pending before a licensing entity in another state, the District

822 of Columbia, or a possession or territory of the United States;

823 2. Has been convicted of or pled nolo contendere to,

824 regardless of adjudication, any felony or misdemeanor related to

825 the practice of a health care profession;

826 3. Has had a health care provider license revoked or

827 suspended by another state, the District of Columbia, or a

828 territory of the United States, or has voluntarily surrendered

829 any such license in lieu of having disciplinary action taken

830 against the license; or

831 4. Has been reported to the National Practitioner Data

832 Bank, unless the applicant has successfully appealed to have his

833 or her name removed from the data bank.

If the reported adverse

834

action was a result of conduct that would not constitute a

835

violation of any law or rule in this state, the board, or the

836

department if there is no board, may:

837

a.

Approve the application;

838

b.

Approve the application with restrictions on the scope

839

of practice of the licensee;

840

c.

Approve the application with placement of the licensee

841

on probation for a period of time and subject to such conditions

842

as the board, or the department if there is no board, may

843

specify, including, but not limited to, requiring the applicant

844

to submit to treatment, attend continuing education courses, or

845

submit to reexamination; or

846

d.

Deny the application.

847 Section 8. Subsection (1) of section 458.315, Florida

848 Statutes, is amended to read:

849 458.315 Temporary certificate for practice in areas of

850 critical need.—

851 (1) A physician

or physician assistant

who is

licensed to

852 practice in any jurisdiction of the United States

and

whose

853 license is currently valid may be issued a temporary certificate

854 for practice in areas of critical need. A physician seeking such

855 certificate must pay an application fee of $300.

A physician

856

assistant licensed to practice in any state of the United States

857

or the District of Columbia whose license is currently valid may

858

be issued a temporary certificate for practice in areas of

859

critical need.

860 Section 9. Subsection (1) of section 459.0076, Florida

861 Statutes, is amended to read:

862 459.0076 Temporary certificate for practice in areas of

863 critical need.—

864 (1) A physician

or physician assistant

who holds a valid

865 license to practice in any jurisdiction of the United States may

866 be issued a temporary certificate for practice in areas of

867 critical need. A physician seeking such certificate must pay an

868 application fee of $300.

A physician assistant licensed to

869

practice in any state of the United States or the District of

870

Columbia whose license is currently valid may be issued a

871

temporary certificate for practice in areas of critical need.

872 Section 10. Section 486.112, Florida Statutes, is amended

873 to read:

874 486.112 Physical Therapy Licensure Compact.—The Physical

875 Therapy Licensure Compact is hereby enacted into law and entered

876 into by this state with all other jurisdictions legally joining

877 therein in the form substantially as follows:

878

879 ARTICLE I

880 PURPOSE AND OBJECTIVES

881

882 (1) The purpose of the compact is to facilitate interstate

883 practice of physical therapy with the goal of improving public

884 access to physical therapy services. The compact preserves the

885 regulatory authority of member states to protect public health

886 and safety through their current systems of state licensure. For

887 purposes of state regulation under the compact, the practice of

888 physical therapy is deemed to have occurred in the state where

889 the patient is located at the time physical therapy is provided

890 to the patient.

891 (2) The compact is designed to achieve all of the following

892 objectives:

893 (a) Increase public access to physical therapy services by

894 providing for the mutual recognition of other member state

895 licenses.

896 (b) Enhance the states’ ability to protect the public’s

897 health and safety.

898 (c) Encourage the cooperation of member states in

899 regulating multistate physical therapy practice.

900 (d) Support spouses of relocating military members.

901 (e) Enhance the exchange of licensure, investigative, and

902 disciplinary information between member states.

903 (f) Allow a remote state to hold a provider of services

904 with a compact privilege in that state accountable to that

905 state’s practice standards.

906

907 ARTICLE II

908 DEFINITIONS

909

910 As used in the compact, and except as otherwise provided,

911 the term:

912 (1) “Active duty military” means full-time duty status in

913 the active uniformed service of the United States, including

914 members of the National Guard and Reserve on active duty orders

915 pursuant to 10 U.S.C. chapter 1209 or chapter 1211.

916 (2) “Adverse action” means disciplinary action taken by a

917 physical therapy licensing board based upon misconduct,

918 unacceptable performance, or a combination of both.

919 (3) “Alternative program” means a nondisciplinary

920 monitoring or practice remediation process approved by a state’s

921 physical therapy licensing board. The term includes, but is not

922 limited to, programs that address substance abuse issues.

923 (4) “Compact privilege” means the authorization granted by

924 a remote state to allow a licensee from another member state to

925 practice as a physical therapist or physical therapist assistant

926 in the remote state under its laws and rules.

927 (5) “Continuing competence” means a requirement, as a

928 condition of license renewal, to provide evidence of

929 participation in, and completion of, educational and

930 professional activities relevant to the practice of physical

931 therapy.

932 (6) “Data system” means the coordinated database and

933 reporting system created by the Physical Therapy Compact

934 Commission for the exchange of information between member states

935 relating to licensees or applicants under the compact, including

936 identifying information, licensure data, investigative

937 information, adverse actions, nonconfidential information

938 related to alternative program participation, any denials of

939 applications for licensure, and other information as specified

940 by commission rule.

941 (7) “Encumbered license” means a license that a physical

942 therapy licensing board has limited in any way.

943 (8) “Executive board” means a group of directors elected or

944 appointed to act on behalf of, and within the powers granted to

945 them by, the commission.

946 (9) “Home state” means the member state that is the

947 licensee’s primary state of residence.

948 (10) “Investigative information” means information,

949 records, and documents received or generated by a physical

950 therapy licensing board pursuant to an investigation.

951 (11) “Jurisprudence requirement” means the assessment of an

952 individual’s knowledge of the laws and rules governing the

953 practice of physical therapy in a specific state.

954 (12) “Licensee” means an individual who currently holds an

955 authorization from a state to practice as a physical therapist

956 or physical therapist assistant.

957 (13) “Member state” means a state that has enacted the

958 compact.

959 (14)

“Party state” means any member state in which a

960

licensee holds a current license or compact privilege or is

961

applying for a license or compact privilege.

962

(15)

“Physical therapist” means an individual licensed by a

963 state to practice physical therapy.

964

(16)

(15)

“Physical therapist assistant” means an individual

965 licensed by a state to assist a physical therapist in specified

966 areas of physical therapy.

967

(17)

(16)

“Physical therapy” or “the practice of physical

968 therapy” means the care and services provided by or under the

969 direction and supervision of a licensed physical therapist.

970

(18)

(17)

“Physical Therapy Compact Commission” or

971 “commission” means the national administrative body whose

972 membership consists of all states that have enacted the compact.

973

(19)

(18)

“Physical therapy licensing board” means the

974 agency of a state which is responsible for the licensing and

975 regulation of physical therapists and physical therapist

976 assistants.

977

(20)

(19)

“Remote state” means a member state other than the

978 home state where a licensee is exercising or seeking to exercise

979 the compact privilege.

980

(21)

(20)

“Rule” means a regulation, principle, or directive

981 adopted by the commission which has the force of law.

982

(22)

(21)

“State” means any state, commonwealth, district,

983 or territory of the United States of America which regulates the

984 practice of physical therapy.

985

986 ARTICLE III

987 STATE PARTICIPATION IN THE COMPACT

988

989 (1) To participate in the compact, a state must do all of

990 the following:

991 (a) Participate fully in the commission’s data system,

992 including using the commission’s unique identifier, as defined

993 by commission rule.

994 (b) Have a mechanism in place for receiving and

995 investigating complaints about licensees.

996 (c) Notify the commission, in accordance with the terms of

997 the compact and rules, of any adverse action or the availability

998 of investigative information regarding a licensee.

999 (d) Fully implement a criminal background check

1000 requirement, within a timeframe established by commission rule,

1001 which uses results from the Federal Bureau of Investigation

1002 record search on criminal background checks to make licensure

1003 decisions in accordance with subsection (2).

1004 (e) Comply with the commission’s rules.

1005 (f) Use a recognized national examination as a requirement

1006 for licensure pursuant to the commission’s rules.

1007 (g) Have continuing competence requirements as a condition

1008 for license renewal.

1009 (2) Upon adoption of the compact, a member state has the

1010 authority to obtain biometric-based information from each

1011 licensee applying for a compact privilege and submit this

1012 information to the Federal Bureau of Investigation for a

1013 criminal background check in accordance with 28 U.S.C. s. 534

1014 and 34 U.S.C. s. 40316.

1015 (3) A member state must grant the compact privilege to a

1016 licensee holding a valid unencumbered license in another member

1017 state in accordance with the terms of the compact and rules.

1018

1019 ARTICLE IV

1020 COMPACT PRIVILEGE

1021

1022 (1) To exercise the compact privilege under the compact, a

1023 licensee must satisfy all of the following conditions:

1024 (a) Hold a license in the home state.

1025 (b) Not have an encumbrance on any state license.

1026 (c) Be eligible for a compact privilege in all member

1027 states in accordance with subsections (4), (7), and (8).

1028 (d) Not have had an adverse action against any license or

1029 compact privilege within the preceding 2 years.

1030 (e) Notify the commission that the licensee is seeking the

1031 compact privilege within a remote state.

1032 (f) Meet any jurisprudence requirements established by the

1033 remote state in which the licensee is seeking a compact

1034 privilege.

1035 (g) Report to the commission adverse action taken by any

1036 nonmember state within 30 days after the date the adverse action

1037 is taken.

1038 (2) The compact privilege is valid until the expiration

1039 date of the home license. The licensee must continue to meet the

1040 requirements of subsection (1) to maintain the compact privilege

1041 in a remote state.

1042 (3) A licensee providing physical therapy in a remote state

1043 under the compact privilege must comply with the laws and rules

1044 of the remote state.

1045 (4) A licensee providing physical therapy in a remote state

1046 is subject to that state’s regulatory authority. A remote state

1047 may, in accordance with due process and that state’s laws,

1048 remove a licensee’s compact privilege in the remote state for a

1049 specific period of time, impose fines, and take any other

1050 necessary actions to protect the health and safety of its

1051 citizens. The licensee is not eligible for a compact privilege

1052 in any member state until the specific period of time for

1053 removal has ended and all fines are paid.

1054 (5) If a home state license is encumbered, the licensee

1055 loses the compact privilege in any remote state until the

1056 following conditions are met:

1057 (a) The home state license is no longer encumbered.

1058 (b) Two years have elapsed from the date of the adverse

1059 action.

1060 (6) Once an encumbered license in the home state is

1061 restored to good standing, the licensee must meet the

1062 requirements of subsection (1) to obtain a compact privilege in

1063 any remote state.

1064 (7) If a licensee’s compact privilege in any remote state

1065 is removed, the licensee loses the compact privilege in all

1066 remote states until all of the following conditions are met:

1067 (a) The specific period of time for which the compact

1068 privilege was removed has ended.

1069 (b) All fines have been paid.

1070 (c) Two years have elapsed from the date of the adverse

1071 action.

1072 (8) Once the requirements of subsection (7) have been met,

1073 the licensee must meet the requirements of subsection (1) to

1074 obtain a compact privilege in a remote state.

1075

1076 ARTICLE V

1077 ACTIVE DUTY MILITARY PERSONNEL

1078 AND THEIR SPOUSES

1079

1080 A licensee who is active duty military or is the spouse of

1081 an individual who is active duty military may choose any of the

1082 following locations to designate his or her home state:

1083 (1) Home of record.

1084 (2) Permanent change of station location.

1085 (3) State of current residence, if it is different from the

1086 home of record or permanent change of station location.

1087

1088 ARTICLE VI

1089 ADVERSE ACTIONS

1090

1091 (1) A home state has exclusive power to impose adverse

1092 action against a license issued by the home state.

1093 (2) A home state may take adverse action based on the

1094 investigative information of a remote state, so long as the home

1095 state follows its own procedures for imposing adverse action.

1096 (3) The compact does not override a member state’s decision

1097 that participation in an alternative program may be used in lieu

1098 of adverse action and that such participation remain nonpublic

1099 if required by the member state’s laws. Member states must

1100 require licensees who enter any alternative programs in lieu of

1101 discipline to agree not to practice in any other member state

1102 during the term of the alternative program without prior

1103 authorization from such other member state.

1104 (4) A member state may investigate actual or alleged

1105 violations of the laws and rules for the practice of physical

1106 therapy committed in any other member state by a physical

1107 therapist or physical therapist assistant practicing under the

1108 compact who holds a license or compact privilege in such other

1109 member state.

1110 (5) A remote state may do any of the following:

1111 (a) Take adverse actions as set forth in subsection (4) of

1112 Article IV against a licensee’s compact privilege in the state.

1113 (b) Issue subpoenas for both hearings and investigations

1114 which require the attendance and testimony of witnesses and the

1115 production of evidence. Subpoenas issued by a physical therapy

1116 licensing board in a

party

member

state for the attendance and

1117 testimony of witnesses or for the production of evidence from

1118 another

party

member

state must be enforced in the latter state

1119 by any court of competent jurisdiction, according to the

1120 practice and procedure of that court applicable to subpoenas

1121 issued in proceedings pending before it. The issuing authority

1122 shall pay any witness fees, travel expenses, mileage, and other

1123 fees required by the service laws of the state where the

1124 witnesses or evidence is located.

1125 (c) If otherwise permitted by state law, recover from the

1126 licensee the costs of investigations and disposition of cases

1127 resulting from any adverse action taken against that licensee.

1128 (6)(a) In addition to the authority granted to a member

1129 state by its respective physical therapy practice act or other

1130 applicable state law, a member state may participate with other

1131 member states in joint investigations of licensees.

1132 (b) Member states shall share any investigative,

1133 litigation, or compliance materials in furtherance of any joint

1134 or individual investigation initiated under the compact.

1135

1136 ARTICLE VII

1137 ESTABLISHMENT OF THE

1138 PHYSICAL THERAPY COMPACT COMMISSION

1139

1140 (1) COMMISSION CREATED.—The member states hereby create and

1141 establish a joint public agency known as the Physical Therapy

1142 Compact Commission:

1143 (a) The commission is an instrumentality of the member

1144 states.

1145 (b) Venue is proper, and judicial proceedings by or against

1146 the commission must be brought solely and exclusively, in a

1147 court of competent jurisdiction where the principal office of

1148 the commission is located. The commission may waive venue and

1149 jurisdictional defenses to the extent it adopts or consents to

1150 participate in alternative dispute resolution proceedings.

1151 (c) The compact may not be construed to be a waiver of

1152 sovereign immunity.

1153 (2) MEMBERSHIP, VOTING, AND MEETINGS.—

1154 (a) Each member state has and is limited to one delegate

1155 selected by that member state’s physical therapy licensing board

1156 to serve on the commission. The delegate must be a current

1157 member of the physical therapy licensing board who is a physical

1158 therapist, a physical therapist assistant, a public member, or

1159 the board administrator.

1160 (b) A delegate may be removed or suspended from office as

1161 provided by the law of the state from which the delegate is

1162 appointed. Any vacancy occurring on the commission must be

1163 filled by the physical therapy licensing board of the member

1164 state for which the vacancy exists.

1165 (c) Each delegate is entitled to one vote with regard to

1166 the adoption of rules and bylaws and shall otherwise have an

1167 opportunity to participate in the business and affairs of the

1168 commission.

1169 (d) A delegate shall vote in person or by such other means

1170 as provided in the bylaws. The bylaws may provide for delegates’

1171 participation in meetings by telephone or other means of

1172 communication.

1173 (e) The commission shall meet at least once during each

1174 calendar year. Additional meetings may be held as set forth in

1175 the bylaws.

1176 (f) All meetings must be open to the public, and public

1177 notice of meetings must be given in the same manner as required

1178 under the rulemaking provisions in Article IX.

1179 (g) The commission or the executive board or other

1180 committees of the commission may convene in a closed, nonpublic

1181 meeting if the commission or executive board or other committees

1182 of the commission must discuss any of the following:

1183 1. Noncompliance of a member state with its obligations

1184 under the compact.

1185 2. The employment, compensation, or discipline of, or other

1186 matters, practices, or procedures related to, specific employees

1187 or other matters related to the commission’s internal personnel

1188 practices and procedures.

1189 3. Current, threatened, or reasonably anticipated

1190 litigation against the commission, executive board, or other

1191 committees of the commission.

1192 4. Negotiation of contracts for the purchase, lease, or

1193 sale of goods, services, or real estate.

1194 5. An accusation of any person of a crime or a formal

1195 censure of any person.

1196 6. Information disclosing trade secrets or commercial or

1197 financial information that is privileged or confidential.

1198 7. Information of a personal nature where disclosure would

1199 constitute a clearly unwarranted invasion of personal privacy.

1200 8. Investigatory records compiled for law enforcement

1201 purposes.

1202 9. Information related to any investigative reports

1203 prepared by or on behalf of or for use of the commission or

1204 other committee charged with responsibility for investigation or

1205 determination of compliance issues pursuant to the compact.

1206 10. Matters specifically exempted from disclosure by

1207 federal or member state statute.

1208 (h) If a meeting, or portion of a meeting, is closed

1209 pursuant to this subsection, the commission’s legal counsel or

1210 designee must certify that the meeting may be closed and must

1211 reference each relevant exempting provision.

1212 (i) The commission shall keep minutes that fully and

1213 clearly describe all matters discussed in a meeting and shall

1214 provide a full and accurate summary of actions taken and the

1215 reasons therefor, including a description of the views

1216 expressed. All documents considered in connection with an action

1217 must be identified in the minutes. All minutes and documents of

1218 a closed meeting must remain under seal, subject to release only

1219 by a majority vote of the commission or order of a court of

1220 competent jurisdiction.

1221 (3) DUTIES.—The commission shall do all of the following:

1222 (a) Establish the fiscal year of the commission.

1223 (b) Establish bylaws.

1224 (c) Maintain its financial records in accordance with the

1225 bylaws.

1226 (d) Meet and take such actions as are consistent with the

1227 provisions of the compact and the bylaws.

1228 (4) POWERS.—The commission may do any of the following:

1229 (a) Adopt uniform rules to facilitate and coordinate

1230 implementation and administration of the compact. The rules have

1231 the force and effect of law and are binding in all member

1232 states.

1233 (b) Bring and prosecute legal proceedings or actions in the

1234 name of the commission, provided that the standing of any state

1235 physical therapy licensing board to sue or be sued under

1236 applicable law is not affected.

1237 (c) Purchase and maintain insurance and bonds.

1238 (d) Borrow, accept, or contract for services of personnel,

1239 including, but not limited to, employees of a member state.

1240 (e) Hire employees and elect or appoint officers; fix the

1241 compensation of, define the duties of, and grant appropriate

1242 authority to such individuals to carry out the purposes of the

1243 compact; and establish the commission’s personnel policies and

1244 programs relating to conflicts of interest, qualifications of

1245 personnel, and other related personnel matters.

1246 (f) Accept any appropriate donations and grants of money,

1247 equipment, supplies, materials, and services and receive, use,

1248 and dispose of the same, provided that at all times the

1249 commission avoids any appearance of impropriety or conflict of

1250 interest.

1251 (g) Lease, purchase, accept appropriate gifts or donations

1252 of, or otherwise own, hold, improve, or use any property, real,

1253 personal, or mixed, provided that at all times the commission

1254 avoids any appearance of impropriety or conflict of interest.

1255 (h) Sell, convey, mortgage, pledge, lease, exchange,

1256 abandon, or otherwise dispose of any property, real, personal,

1257 or mixed.

1258 (i) Establish a budget and make expenditures.

1259 (j) Borrow money.

1260 (k) Appoint committees, including standing committees

1261 composed of members, state regulators, state legislators or

1262 their representatives, and consumer representatives, and such

1263 other interested persons as may be designated in the compact and

1264 the bylaws.

1265 (l) Provide information to, receive information from, and

1266 cooperate with law enforcement agencies.

1267 (m) Establish and elect an executive board.

1268 (n) Perform such other functions as may be necessary or

1269 appropriate to achieve the purposes of the compact consistent

1270 with the state regulation of physical therapy licensure and

1271 practice.

1272 (5) THE EXECUTIVE BOARD.—

1273 (a) The executive board may act on behalf of the commission

1274 according to the terms of the compact.

1275 (b) The executive board shall be composed of the following

1276 nine members:

1277 1. Seven voting members who are elected by the commission

1278 from the current membership of the commission.

1279 2. One ex officio, nonvoting member from the recognized

1280 national physical therapy professional association.

1281 3. One ex officio, nonvoting member from the recognized

1282 membership organization of the physical therapy licensing

1283 boards.

1284 (c) The ex officio members shall be selected by their

1285 respective organizations.

1286 (d) The commission may remove any member of the executive

1287 board as provided in its bylaws.

1288 (e) The executive board shall meet at least annually.

1289 (f) The executive board shall do all of the following:

1290 1. Recommend to the entire commission changes to the rules

1291 or bylaws, compact legislation, fees paid by compact member

1292 states, such as annual dues, and any commission compact fee

1293 charged to licensees for the compact privilege.

1294 2. Ensure compact administration services are appropriately

1295 provided, contractually or otherwise.

1296 3. Prepare and recommend the budget.

1297 4. Maintain financial records on behalf of the commission.

1298 5. Monitor compact compliance of member states and provide

1299 compliance reports to the commission.

1300 6. Establish additional committees as necessary.

1301 7. Perform other duties as provided in the rules or bylaws.

1302 (6) FINANCING OF THE COMMISSION.—

1303 (a) The commission shall pay, or provide for the payment

1304 of, the reasonable expenses of its establishment, organization,

1305 and ongoing activities.

1306 (b) The commission may accept any appropriate revenue

1307 sources, donations, and grants of money, equipment, supplies,

1308 materials, and services.

1309 (c) The commission may levy and collect an annual

1310 assessment from each member state or impose fees on other

1311 parties to cover the cost of the operations and activities of

1312 the commission and its staff. Such assessments and fees must

1313 total to an amount sufficient to cover the commission’s annual

1314 budget as approved each year for which revenue is not provided

1315 by other sources. The aggregate annual assessment amount must be

1316 allocated based upon a formula to be determined by the

1317 commission, which shall adopt a rule binding upon all member

1318 states.

1319 (d) The commission may not incur obligations of any kind

1320 before securing the funds adequate to meet such obligations; nor

1321 may the commission pledge the credit of any of the member

1322 states, except by and with the authority of the member state.

1323 (e) The commission shall keep accurate accounts of all

1324 receipts and disbursements. The receipts and disbursements of

1325 the commission are subject to the audit and accounting

1326 procedures established under its bylaws. However, all receipts

1327 and disbursements of funds handled by the commission must be

1328 audited yearly by a certified or licensed public accountant, and

1329 the report of the audit must be included in and become part of

1330 the annual report of the commission.

1331 (7) QUALIFIED IMMUNITY, DEFENSE, AND INDEMNIFICATION.—

1332 (a) The members, officers, executive director, employees,

1333 and representatives of the commission are immune from suit and

1334 liability, whether personally or in their official capacity, for

1335 any claim for damage to or loss of property or personal injury

1336 or other civil liability caused by or arising out of any actual

1337 or alleged act, error, or omission that occurred, or that the

1338 person against whom the claim is made had a reasonable basis for

1339 believing occurred, within the scope of commission employment,

1340 duties, or responsibilities. However, this paragraph may not be

1341 construed to protect any such person from suit or liability for

1342 any damage, loss, injury, or liability caused by the

1343 intentional, willful, or wanton misconduct of that person.

1344 (b) The commission shall defend any member, officer,

1345 executive director, employee, or representative of the

1346 commission in any civil action seeking to impose liability

1347 arising out of any actual or alleged act, error, or omission

1348 that occurred within the scope of commission employment, duties,

1349 or responsibilities, or that the person against whom the claim

1350 is made had a reasonable basis for believing occurred within the

1351 scope of commission employment, duties, or responsibilities.

1352 However, this subsection may not be construed to prohibit any

1353 member, officer, executive director, employee, or representative

1354 of the commission from retaining his or her own counsel or to

1355 require the commission to defend such person if the actual or

1356 alleged act, error, or omission resulted from that person’s

1357 intentional, willful, or wanton misconduct.

1358 (c) The commission shall indemnify and hold harmless any

1359 member, officer, executive director, employee, or representative

1360 of the commission for the amount of any settlement or judgment

1361 obtained against that person arising out of any actual or

1362 alleged act, error, or omission that occurred within the scope

1363 of commission employment, duties, or responsibilities, or that

1364 such person had a reasonable basis for believing occurred within

1365 the scope of commission employment, duties, or responsibilities,

1366 provided that the actual or alleged act, error, or omission did

1367 not result from the intentional, willful, or wanton misconduct

1368 of that person.

1369

1370 ARTICLE VIII

1371 DATA SYSTEM

1372

1373 (1) The commission shall provide for the development,

1374 maintenance, and use of a coordinated database and reporting

1375 system containing licensure, adverse action, and investigative

1376 information on all licensees in member states.

1377 (2) Notwithstanding any other provision of state law to the

1378 contrary, a member state shall submit a uniform data set to the

1379 data system on all individuals to whom the compact is applicable

1380 as required by the rules of the commission, which data set must

1381 include all of the following:

1382 (a) Identifying information.

1383 (b) Licensure data.

1384 (c) Investigative information.

1385 (d) Adverse actions against a license or compact privilege.

1386 (e) Nonconfidential information related to alternative

1387 program participation.

1388 (f) Any denial of application for licensure, and the reason

1389 for such denial.

1390 (g) Other information that may facilitate the

1391 administration of the compact, as determined by the rules of the

1392 commission.

1393 (3) Investigative information in the system pertaining to a

1394 licensee in any member state must be available only to other

1395

party

member

states.

1396 (4) The commission shall promptly notify all member states

1397 of any adverse action taken against a licensee or an individual

1398 applying for a license in a member state. Adverse action

1399 information pertaining to a licensee in any member state must be

1400 available to all other member states.

1401 (5) Member states contributing information to the data

1402 system may designate information that may not be shared with the

1403 public without the express permission of the contributing state.

1404 (6) Any information submitted to the data system which is

1405 subsequently required to be expunged by the laws of the member

1406 state contributing the information must be removed from the data

1407 system.

1408

1409 ARTICLE IX

1410 RULEMAKING

1411

1412 (1) The commission shall exercise its rulemaking powers

1413 pursuant to the criteria set forth in this article and the rules

1414 adopted thereunder. Rules and amendments become binding as of

1415 the date specified in each rule or amendment.

1416 (2) If a majority of the legislatures of the member states

1417 rejects a rule by enactment of a statute or resolution in the

1418 same manner used to adopt the compact within 4 years after the

1419 date of adoption of the rule, such rule does not have further

1420 force and effect in any member state.

1421 (3) Rules or amendments to the rules must be adopted at a

1422 regular or special meeting of the commission.

1423 (4) Before adoption of a final rule by the commission, and

1424 at least 30 days before the meeting at which the rule will be

1425 considered and voted upon, the commission must file a notice of

1426 proposed rulemaking on all of the following:

1427 (a) The website of the commission or another publicly

1428 accessible platform.

1429 (b) The website of each member state physical therapy

1430 licensing board or another publicly accessible platform or the

1431 publication in which each state would otherwise publish proposed

1432 rules.

1433 (5) The notice of proposed rulemaking must include all of

1434 the following:

1435 (a) The proposed date, time, and location of the meeting in

1436 which the rule or amendment will be considered and voted upon.

1437 (b) The text of the proposed rule or amendment and the

1438 reason for the proposed rule.

1439 (c) A request for comments on the proposed rule or

1440 amendment from any interested person.

1441 (d) The manner in which interested persons may submit

1442 notice to the commission of their intention to attend the public

1443 hearing and any written comments.

1444 (6) Before adoption of a proposed rule or amendment, the

1445 commission must allow persons to submit written data, facts,

1446 opinions, and arguments, which must be made available to the

1447 public.

1448 (7) The commission must grant an opportunity for a public

1449 hearing before it adopts a rule or an amendment if a hearing is

1450 requested by any of the following:

1451 (a) At least 25 persons.

1452 (b) A state or federal governmental subdivision or agency.

1453 (c) An association having at least 25 members.

1454 (8) If a scheduled public hearing is held on the proposed

1455 rule or amendment, the commission must publish the date, time,

1456 and location of the hearing. If the hearing is held through

1457 electronic means, the commission must publish the mechanism for

1458 access to the electronic hearing.

1459 (a) All persons wishing to be heard at the hearing must

1460 notify the executive director of the commission or another

1461 designated member in writing of their desire to appear and

1462 testify at the hearing at least 5 business days before the

1463 scheduled date of the hearing.

1464 (b) Hearings must be conducted in a manner providing each

1465 person who wishes to comment a fair and reasonable opportunity

1466 to comment orally or in writing.

1467 (c) All hearings must be recorded. A copy of the recording

1468 must be made available on request.

1469 (d) This article may not be construed to require a separate

1470 hearing on each rule. Rules may be grouped for the convenience

1471 of the commission at hearings required by this article.

1472 (9) Following the scheduled hearing date, or by the close

1473 of business on the scheduled hearing date if the hearing was not

1474 held, the commission shall consider all written and oral

1475 comments received.

1476 (10) If no written notice of intent to attend the public

1477 hearing by interested parties is received, the commission may

1478 proceed with adoption of the proposed rule without a public

1479 hearing.

1480 (11) The commission shall, by majority vote of all members,

1481 take final action on the proposed rule and shall determine the

1482 effective date of the rule, if any, based on the rulemaking

1483 record and the full text of the rule.

1484 (12) Upon determination that an emergency exists, the

1485 commission may consider and adopt an emergency rule without

1486 prior notice, opportunity for comment, or hearing, provided that

1487 the usual rulemaking procedures provided in the compact and in

1488 this article are retroactively applied to the rule as soon as

1489 reasonably possible, in no event later than 90 days after the

1490 effective date of the rule. For the purposes of this subsection,

1491 an emergency rule is one that must be adopted immediately in

1492 order to do any of the following:

1493 (a) Meet an imminent threat to public health, safety, or

1494 welfare.

1495 (b) Prevent a loss of commission or member state funds.

1496 (c) Meet a deadline for the adoption of an administrative

1497 rule established by federal law or rule.

1498 (d) Protect public health and safety.

1499 (13) The commission or an authorized committee of the

1500 commission may direct revisions to a previously adopted rule or

1501 amendment for purposes of correcting typographical errors,

1502 errors in format, errors in consistency, or grammatical errors.

1503 Public notice of any revisions must be posted on the website of

1504 the commission. The revision is subject to challenge by any

1505 person for a period of 30 days after posting. The revision may

1506 be challenged only on grounds that the revision results in a

1507 material change to a rule. A challenge must be made in writing

1508 and delivered to the chair of the commission before the end of

1509 the notice period. If a challenge is not made, the revision

1510 takes effect without further action. If the revision is

1511 challenged, the revision may not take effect without the

1512 approval of the commission.

1513

1514 ARTICLE X

1515 OVERSIGHT, DISPUTE RESOLUTION,

1516 AND ENFORCEMENT

1517

1518 (1) OVERSIGHT.—

1519 (a) The executive, legislative, and judicial branches of

1520 state government in each member state shall enforce the compact

1521 and take all actions necessary and appropriate to carry out the

1522 compact’s purposes and intent. The provisions of the compact and

1523 the rules adopted pursuant thereto shall have standing as

1524 statutory law.

1525 (b) All courts shall take judicial notice of the compact

1526 and the rules in any judicial or administrative proceeding in a

1527 member state pertaining to the subject matter of the compact

1528 which may affect the powers, responsibilities, or actions of the

1529 commission.

1530 (c) The commission is entitled to receive service of

1531 process in any such proceeding and has standing to intervene in

1532 such a proceeding for all purposes. Failure to provide service

1533 of process to the commission renders a judgment or an order void

1534 as to the commission, the compact, or the adopted rules.

1535 (2) DEFAULT, TECHNICAL ASSISTANCE, AND TERMINATION.—

1536 (a) If the commission determines that a member state has

1537 defaulted in the performance of its obligations or

1538 responsibilities under the compact or the adopted rules, the

1539 commission must do all of the following:

1540 1. Provide written notice to the defaulting state and other

1541 member states of the nature of the default, the proposed means

1542 of curing the default, and any other action to be taken by the

1543 commission.

1544 2. Provide remedial training and specific technical

1545 assistance regarding the default.

1546 (b) If a state in default fails to cure the default, the

1547 defaulting state may be terminated from the compact upon an

1548 affirmative vote of a majority of the member states, and all

1549 rights, privileges, and benefits conferred by the compact may be

1550 terminated on the effective date of termination. A cure of the

1551 default does not relieve the offending state of obligations or

1552 liabilities incurred during the period of default.

1553 (c) Termination of membership in the compact may be imposed

1554 only after all other means of securing compliance have been

1555 exhausted. The commission shall give notice of intent to suspend

1556 or terminate a defaulting member state to the governor and

1557 majority and minority leaders of the defaulting state’s

1558 legislature and to each of the member states.

1559 (d) A state that has been terminated from the compact is

1560 responsible for all assessments, obligations, and liabilities

1561 incurred through the effective date of termination, including

1562 obligations that extend beyond the effective date of

1563 termination.

1564 (e) The commission does not bear any costs related to a

1565 state that is found to be in default or that has been terminated

1566 from the compact, unless agreed upon in writing between the

1567 commission and the defaulting state.

1568 (f) The defaulting state may appeal the action of the

1569 commission by petitioning the United States District Court for

1570 the District of Columbia or the federal district where the

1571 commission has its principal offices. The prevailing member

1572 shall be awarded all costs of such litigation, including

1573 reasonable attorney fees.

1574 (3) DISPUTE RESOLUTION.—

1575 (a) Upon request by a member state, the commission must

1576 attempt to resolve disputes related to the compact which arise

1577 among member states and between member and nonmember states.

1578 (b) The commission shall adopt a rule providing for both

1579 mediation and binding dispute resolution for disputes as

1580 appropriate.

1581 (4) ENFORCEMENT.—

1582 (a) The commission, in the reasonable exercise of its

1583 discretion, shall enforce the compact and the commission’s

1584 rules.

1585 (b) By majority vote, the commission may initiate legal

1586 action in the United States District Court for the District of

1587 Columbia or the federal district where the commission has its

1588 principal offices against a member state in default to enforce

1589 compliance with the provisions of the compact and its adopted

1590 rules and bylaws. The relief sought may include both injunctive

1591 relief and damages. In the event judicial enforcement is

1592 necessary, the prevailing member shall be awarded all costs of

1593 such litigation, including reasonable attorney fees.

1594 (c) The remedies under this article are not the exclusive

1595 remedies of the commission. The commission may pursue any other

1596 remedies available under federal or state law.

1597

1598 ARTICLE XI

1599 DATE OF IMPLEMENTATION OF THE

1600 PHYSICAL THERAPY COMPACT

1601 AND ASSOCIATED RULES;

1602 WITHDRAWAL; AND AMENDMENTS

1603

1604 (1) The compact becomes effective on the date that the

1605 compact statute is enacted into law in the tenth member state.

1606 The provisions that become effective at that time are limited to

1607 the powers granted to the commission relating to assembly and

1608 the adoption of rules. Thereafter, the commission shall meet and

1609 exercise rulemaking powers necessary for the implementation and

1610 administration of the compact.

1611 (2) Any state that joins the compact subsequent to the

1612 commission’s initial adoption of the rules is subject to the

1613 rules as they exist on the date that the compact becomes law in

1614 that state. Any rule that has been previously adopted by the

1615 commission has the full force and effect of law on the day the

1616 compact becomes law in that state.

1617 (3) Any member state may withdraw from the compact by

1618 enacting a statute repealing the same.

1619 (a) A member state’s withdrawal does not take effect until

1620 6 months after enactment of the repealing statute.

1621 (b) Withdrawal does not affect the continuing requirement

1622 of the withdrawing state’s physical therapy licensing board to

1623 comply with the investigative and adverse action reporting

1624 requirements of this act before the effective date of

1625 withdrawal.

1626 (4) The compact may not be construed to invalidate or

1627 prevent any physical therapy licensure agreement or other

1628 cooperative arrangement between a member state and a nonmember

1629 state which does not conflict with the provisions of the

1630 compact.

1631 (5) The compact may be amended by the member states. An

1632 amendment to the compact does not become effective and binding

1633 upon any member state until it is enacted into the laws of all

1634 member states.

1635

1636 ARTICLE XII

1637 CONSTRUCTION AND SEVERABILITY

1638

1639 The compact must be liberally construed so as to carry out

1640 the purposes thereof. The provisions of the compact are

1641 severable, and if any phrase, clause, sentence, or provision of

1642 the compact is declared to be contrary to the constitution of

1643 any

party

member

state or of the United States or the

1644 applicability thereof to any government, agency, person, or

1645 circumstance is held invalid, the validity of the remainder of

1646 the compact and the applicability thereof to any government,

1647 agency, person, or circumstance is not affected thereby. If the

1648 compact is held contrary to the constitution of any

party

member

1649 state, the compact remains in full force and effect as to the

1650 remaining

party

member

states and in full force and effect as to

1651 the

party

member

state affected as to all severable matters.

1652 Section 11. Paragraph (d) of subsection (3) of section

1653 766.1115, Florida Statutes, is amended to read:

1654 766.1115 Health care providers; creation of agency

1655 relationship with governmental contractors.—

1656 (3) DEFINITIONS.—As used in this section, the term:

1657 (d) “Health care provider” or “provider” means:

1658 1. A birth center licensed under chapter 383.

1659 2. An ambulatory surgical center licensed under chapter

1660 395.

1661 3. A hospital licensed under chapter 395.

1662 4. A physician or physician assistant licensed under

1663 chapter 458.

1664 5. An osteopathic physician or osteopathic physician

1665 assistant licensed under chapter 459.

1666 6. A chiropractic physician licensed under chapter 460.

1667 7. A podiatric physician licensed under chapter 461.

1668 8. A registered nurse, nurse midwife, licensed practical

1669 nurse, or advanced practice registered nurse licensed or

1670 registered under part I of chapter 464 or any facility which

1671 employs nurses licensed or registered under part I of chapter

1672 464 to supply all or part of the care delivered under this

1673 section.

1674 9. A midwife licensed under chapter 467.

1675 10. A health maintenance organization certificated under

1676 part I of chapter 641.

1677 11. A health care professional association and its

1678 employees or a corporate medical group and its employees.

1679 12. Any other medical facility the primary purpose of which

1680 is to deliver human medical diagnostic services or which

1681 delivers nonsurgical human medical treatment, and which includes

1682 an office maintained by a provider.

1683 13. A dentist or dental hygienist licensed under chapter

1684 466.

1685 14. A free clinic that delivers only medical diagnostic

1686 services or nonsurgical medical treatment free of charge to all

1687 low-income recipients.

1688 15. Any other health care professional, practitioner,

1689 provider, or facility under contract with a governmental

1690 contractor, including a student enrolled in an accredited

1691 program that prepares the student for licensure as any one of

1692 the professionals listed in subparagraphs 4.-9

. a

nd 13

.

1693

1694 The term includes any nonprofit corporation qualified as exempt

1695 from federal income taxation under s. 501(a) of the Internal

1696 Revenue Code, and described in s. 501(c) of the Internal Revenue

1697 Code, which delivers health care services provided by licensed

1698 professionals listed in this paragraph, any federally funded

1699 community health center, and any volunteer corporation or

1700 volunteer health care provider that delivers health care

1701 services.

1702 Section 12. Except as otherwise expressly provided in this

1703 act and except for this section, which shall take effect upon

1704 this act becoming a law, or, if this act fails to become a law

1705 until after June 1, 2025, it shall take effect upon becoming a

1706 law and shall operate retroactively to June 1, 2025, this act

1707 shall take effect July 1, 2025.

Volver al texto completo